MEDS ▲ +20.7% - DataMEDS AI, Inc.
$MEDS - DataMEDS AI Reports 50% Sequential Revenue Growth in Third Quarter 2026 From Second Quarter 2026, Delivers Net Profit Per Share of $2.72 and Provides Business Update
13-NOV-2026 10:20 AM ET
Share this post
More filings for $MEDS
MEDS - DataMEDS AI, Inc. - SEC Filing Update (10-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 11, 2026MEDS ▲ +7.7% - DataMEDS AI, Inc.Nov 9, 2026MEDS ▲ +7.9% - DataMEDS AI, Inc.Nov 5, 2026MEDS ▼ -7.1% - DataMEDS AI, Inc.Nov 3, 2026MEDS ▲ +10.3% - DataMEDS AI, Inc.Nov 2, 2026MEDS ▲ +1.3% - DataMEDS AI, Inc.Oct 23, 2026
View full $MEDS filing history →💬 Comments
Loading comments…
Leave a comment